The Trump administration is proposing a new rule to keep hospitals from marking up discounted drugs for Medicare patients.
Progress Software (PRGS) looks undervalued after a 20% YTD drop—trading at <10x FCF with improving retention and resilience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results